Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival
Gespeichert in:
| Veröffentlicht in: | European journal of neurology 2022-01, Vol.29 (1), p.e7-e8 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e8 |
|---|---|
| container_issue | 1 |
| container_start_page | e7 |
| container_title | European journal of neurology |
| container_volume | 29 |
| creator | Jakubikova, Michala Tyblova, Michaela Tesar, Adam Magda, Horakova Daniela, Vlazna Irena, Rysankova Iveta, Novakova Kristyna, Doleckova Pavel, Dusek Jiri, Pitha Stanislav, Vohanka Josef, Bednarik |
| description | |
| doi_str_mv | 10.1111/ene.15158 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8653190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2607541999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4718-db1ce452a2f9e06aab2ac353e6997bea372338f199e11e057c0eb89ead91359b3</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhiMEoqVw4AWQJS5wSGvHcRJfkKplgUoV5QBcrYkz6bpK4sV2Uu2NR-AFeDmehIEtVUHCF4_kb37_M3-WPRX8WNA5wQmPhRKquZcdirJqciGluE-1VCJXgouD7FGMV5zzoi74w-xAlpXWvKkOs-8fAnbOJrcg68EmHyLrfWDAIi4YkFk_h4jM92x18fns9Y-v34RmbuqRevxEFRt3ENMGJwfsMsDiIttCcjilyK5d2jCYmCcpGAbmxi39wfydJsv8nKwfkcUEaY6EdyzOYXELDI-zBz0MEZ_c3EfZpzfrj6t3-fnF27PV6Xluy1o0edcKi6UqoOg18gqgLcBKJZGmrFsEWRdSNr3QGoVArmrLsW00QqdpRbqVR9mrve52bkfsLJknv2Yb3AhhZzw48_fL5Dbm0i-mqZQUmpPAixuB4L_MGJMZXbQ4DDChn6MpVFOVqioaQejzf9ArWvFE45mi4rUqyaYm6uWessHHGLC_NSO4-RW6odDN79CJfXbX_S35J2UCTvbAtRtw938ls36_3kv-BHwfus8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2607541999</pqid></control><display><type>article</type><title>Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Jakubikova, Michala ; Tyblova, Michaela ; Tesar, Adam ; Magda, Horakova ; Daniela, Vlazna ; Irena, Rysankova ; Iveta, Novakova ; Kristyna, Doleckova ; Pavel, Dusek ; Jiri, Pitha ; Stanislav, Vohanka ; Josef, Bednarik</creator><creatorcontrib>Jakubikova, Michala ; Tyblova, Michaela ; Tesar, Adam ; Magda, Horakova ; Daniela, Vlazna ; Irena, Rysankova ; Iveta, Novakova ; Kristyna, Doleckova ; Pavel, Dusek ; Jiri, Pitha ; Stanislav, Vohanka ; Josef, Bednarik</creatorcontrib><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.15158</identifier><identifier>PMID: 34699086</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>COVID-19 ; Humans ; Letters to the Editor ; Muscle and MNJ Disorders ; Myasthenia ; Myasthenia gravis ; Myasthenia Gravis - complications ; Neuromuscular junctions ; SARS-CoV-2 ; Thymectomy</subject><ispartof>European journal of neurology, 2022-01, Vol.29 (1), p.e7-e8</ispartof><rights>2021 European Academy of Neurology</rights><rights>Copyright © 2022 European Academy of Neurology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4718-db1ce452a2f9e06aab2ac353e6997bea372338f199e11e057c0eb89ead91359b3</citedby><cites>FETCH-LOGICAL-c4718-db1ce452a2f9e06aab2ac353e6997bea372338f199e11e057c0eb89ead91359b3</cites><orcidid>0000-0001-5554-4839</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.15158$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.15158$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,781,785,886,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34699086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jakubikova, Michala</creatorcontrib><creatorcontrib>Tyblova, Michaela</creatorcontrib><creatorcontrib>Tesar, Adam</creatorcontrib><creatorcontrib>Magda, Horakova</creatorcontrib><creatorcontrib>Daniela, Vlazna</creatorcontrib><creatorcontrib>Irena, Rysankova</creatorcontrib><creatorcontrib>Iveta, Novakova</creatorcontrib><creatorcontrib>Kristyna, Doleckova</creatorcontrib><creatorcontrib>Pavel, Dusek</creatorcontrib><creatorcontrib>Jiri, Pitha</creatorcontrib><creatorcontrib>Stanislav, Vohanka</creatorcontrib><creatorcontrib>Josef, Bednarik</creatorcontrib><title>Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><subject>COVID-19</subject><subject>Humans</subject><subject>Letters to the Editor</subject><subject>Muscle and MNJ Disorders</subject><subject>Myasthenia</subject><subject>Myasthenia gravis</subject><subject>Myasthenia Gravis - complications</subject><subject>Neuromuscular junctions</subject><subject>SARS-CoV-2</subject><subject>Thymectomy</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFu1DAQhiMEoqVw4AWQJS5wSGvHcRJfkKplgUoV5QBcrYkz6bpK4sV2Uu2NR-AFeDmehIEtVUHCF4_kb37_M3-WPRX8WNA5wQmPhRKquZcdirJqciGluE-1VCJXgouD7FGMV5zzoi74w-xAlpXWvKkOs-8fAnbOJrcg68EmHyLrfWDAIi4YkFk_h4jM92x18fns9Y-v34RmbuqRevxEFRt3ENMGJwfsMsDiIttCcjilyK5d2jCYmCcpGAbmxi39wfydJsv8nKwfkcUEaY6EdyzOYXELDI-zBz0MEZ_c3EfZpzfrj6t3-fnF27PV6Xluy1o0edcKi6UqoOg18gqgLcBKJZGmrFsEWRdSNr3QGoVArmrLsW00QqdpRbqVR9mrve52bkfsLJknv2Yb3AhhZzw48_fL5Dbm0i-mqZQUmpPAixuB4L_MGJMZXbQ4DDChn6MpVFOVqioaQejzf9ArWvFE45mi4rUqyaYm6uWessHHGLC_NSO4-RW6odDN79CJfXbX_S35J2UCTvbAtRtw938ls36_3kv-BHwfus8</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Jakubikova, Michala</creator><creator>Tyblova, Michaela</creator><creator>Tesar, Adam</creator><creator>Magda, Horakova</creator><creator>Daniela, Vlazna</creator><creator>Irena, Rysankova</creator><creator>Iveta, Novakova</creator><creator>Kristyna, Doleckova</creator><creator>Pavel, Dusek</creator><creator>Jiri, Pitha</creator><creator>Stanislav, Vohanka</creator><creator>Josef, Bednarik</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5554-4839</orcidid></search><sort><creationdate>202201</creationdate><title>Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival</title><author>Jakubikova, Michala ; Tyblova, Michaela ; Tesar, Adam ; Magda, Horakova ; Daniela, Vlazna ; Irena, Rysankova ; Iveta, Novakova ; Kristyna, Doleckova ; Pavel, Dusek ; Jiri, Pitha ; Stanislav, Vohanka ; Josef, Bednarik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4718-db1ce452a2f9e06aab2ac353e6997bea372338f199e11e057c0eb89ead91359b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19</topic><topic>Humans</topic><topic>Letters to the Editor</topic><topic>Muscle and MNJ Disorders</topic><topic>Myasthenia</topic><topic>Myasthenia gravis</topic><topic>Myasthenia Gravis - complications</topic><topic>Neuromuscular junctions</topic><topic>SARS-CoV-2</topic><topic>Thymectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jakubikova, Michala</creatorcontrib><creatorcontrib>Tyblova, Michaela</creatorcontrib><creatorcontrib>Tesar, Adam</creatorcontrib><creatorcontrib>Magda, Horakova</creatorcontrib><creatorcontrib>Daniela, Vlazna</creatorcontrib><creatorcontrib>Irena, Rysankova</creatorcontrib><creatorcontrib>Iveta, Novakova</creatorcontrib><creatorcontrib>Kristyna, Doleckova</creatorcontrib><creatorcontrib>Pavel, Dusek</creatorcontrib><creatorcontrib>Jiri, Pitha</creatorcontrib><creatorcontrib>Stanislav, Vohanka</creatorcontrib><creatorcontrib>Josef, Bednarik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jakubikova, Michala</au><au>Tyblova, Michaela</au><au>Tesar, Adam</au><au>Magda, Horakova</au><au>Daniela, Vlazna</au><au>Irena, Rysankova</au><au>Iveta, Novakova</au><au>Kristyna, Doleckova</au><au>Pavel, Dusek</au><au>Jiri, Pitha</au><au>Stanislav, Vohanka</au><au>Josef, Bednarik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2022-01</date><risdate>2022</risdate><volume>29</volume><issue>1</issue><spage>e7</spage><epage>e8</epage><pages>e7-e8</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>34699086</pmid><doi>10.1111/ene.15158</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-5554-4839</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1351-5101 |
| ispartof | European journal of neurology, 2022-01, Vol.29 (1), p.e7-e8 |
| issn | 1351-5101 1468-1331 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8653190 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | COVID-19 Humans Letters to the Editor Muscle and MNJ Disorders Myasthenia Myasthenia gravis Myasthenia Gravis - complications Neuromuscular junctions SARS-CoV-2 Thymectomy |
| title | Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T13%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20factors%20for%20a%20severe%20course%20of%20COVID%E2%80%9019%20infection%20in%20myasthenia%20gravis%20patients%20with%20an%20overall%20impact%20on%20myasthenic%20outcome%20status%20and%20survival&rft.jtitle=European%20journal%20of%20neurology&rft.au=Jakubikova,%20Michala&rft.date=2022-01&rft.volume=29&rft.issue=1&rft.spage=e7&rft.epage=e8&rft.pages=e7-e8&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.15158&rft_dat=%3Cproquest_pubme%3E2607541999%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2607541999&rft_id=info:pmid/34699086&rfr_iscdi=true |